Charles K. Marlowe

2.0k total citations · 1 hit paper
23 papers, 1.6k citations indexed

About

Charles K. Marlowe is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Charles K. Marlowe has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Charles K. Marlowe's work include Chemical Synthesis and Analysis (8 papers), Click Chemistry and Applications (4 papers) and Peptidase Inhibition and Analysis (4 papers). Charles K. Marlowe is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Click Chemistry and Applications (4 papers) and Peptidase Inhibition and Analysis (4 papers). Charles K. Marlowe collaborates with scholars based in United States, Japan and Australia. Charles K. Marlowe's co-authors include Paul A. Bartlett, Robert S. Kania, Ronald N. Zuckermann, Reyna J. Simon, Steven C. Banville, Verena D. Huebner, David A. Jewell, Simon Ng, Lane A. Clizbe and Larry E. Overman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Charles K. Marlowe

23 papers receiving 1.5k citations

Hit Papers

Peptoids: a modular approach to drug discovery. 1992 2026 2003 2014 1992 250 500 750

Peers

Charles K. Marlowe
Martin Quibell United Kingdom
Jack Sadowsky United States
John Offer United Kingdom
Stephen P. Hale United States
Kaycie M. Deyle Switzerland
Huy N. Hoang Australia
Charles K. Marlowe
Citations per year, relative to Charles K. Marlowe Charles K. Marlowe (= 1×) peers Kleomenis Barlos

Countries citing papers authored by Charles K. Marlowe

Since Specialization
Citations

This map shows the geographic impact of Charles K. Marlowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles K. Marlowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles K. Marlowe more than expected).

Fields of papers citing papers by Charles K. Marlowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles K. Marlowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles K. Marlowe. The network helps show where Charles K. Marlowe may publish in the future.

Co-authorship network of co-authors of Charles K. Marlowe

This figure shows the co-authorship network connecting the top 25 collaborators of Charles K. Marlowe. A scholar is included among the top collaborators of Charles K. Marlowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles K. Marlowe. Charles K. Marlowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santiago, Marina, et al.. (2024). Activation of CB2 Receptors by (−)-Cannabichromene but Not (+)-Cannabichromene. Cannabis and Cannabinoid Research. 10(1). e94–e101. 1 indexed citations
2.
Agua, Alon, Philip J. Barr, Charles K. Marlowe, & Michael C. Pirrung. (2021). Cannabichromene Racemization and Absolute Stereochemistry Based on a Cannabicyclol Analog. The Journal of Organic Chemistry. 86(12). 8036–8040. 12 indexed citations
3.
Levy, Daniel E., Charles K. Marlowe, Ming Bao, et al.. (2002). Hydroxamate based inhibitors of adenylyl cyclase. Part 1: The effect of acyclic linkers on P-site binding. Bioorganic & Medicinal Chemistry Letters. 12(21). 3085–3088. 8 indexed citations
4.
Zhu, Bing‐Yan, Wenrong Huang, Ting Su, et al.. (2001). Discovery of Transition State Factor Xa Inhibitors as Potential Anticoagulant Agents. Current Topics in Medicinal Chemistry. 1(2). 101–119. 8 indexed citations
5.
Su, Ting, Yanhong Wu, Charles K. Marlowe, et al.. (2001). Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(17). 2279–2282. 8 indexed citations
6.
7.
Sinha, Uma, J Malinowski, Bing Zhu, et al.. (2000). Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis. European Journal of Pharmacology. 395(1). 51–59. 34 indexed citations
8.
Mullenbach, Guy T., Jeffrey M. Blaney, Susan M. Rosenberg, et al.. (1998). Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality. Protein Engineering Design and Selection. 11(6). 473–480. 9 indexed citations
9.
Siegmund, Aaron C., et al.. (1996). Solid phase organic synthesis (SPOS): A novel route to diketopiperazines and diketomorpholines. Molecular Diversity. 1(2). 125–134. 40 indexed citations
11.
Kania, Robert S., Ronald N. Zuckermann, & Charles K. Marlowe. (1994). Free C-Terminal Resin-Bound Peptides: Reversal of Peptide Orientation via A Cyclization/Cleavage Protocol. Journal of the American Chemical Society. 116(19). 8835–8836. 25 indexed citations
12.
Marlowe, Charles K.. (1993). Peptide cyclization on TFA labile resin using the trimethylsilyl (TMSE) ester as an orthogonal protecting group. Bioorganic & Medicinal Chemistry Letters. 3(3). 437–440. 12 indexed citations
13.
Simon, Reyna J., Robert S. Kania, Ronald N. Zuckermann, et al.. (1992). Peptoids: a modular approach to drug discovery.. Proceedings of the National Academy of Sciences. 89(20). 9367–9371. 772 indexed citations breakdown →
14.
Yang, Chi Ching, Charles K. Marlowe, & Robert S. Kania. (1991). Efficient method for regioselective isoprenylation of cysteine thiols in unprotected peptides. Journal of the American Chemical Society. 113(8). 3177–3178. 31 indexed citations
15.
Bartlett, Paul A., Charles K. Marlowe, Peter P. Giannousis, & John E. Hanson. (1987). Phosphorus-containing Peptide Analogs as Peptidase Inhibitors. Cold Spring Harbor Symposia on Quantitative Biology. 52(0). 83–90. 23 indexed citations
16.
Bartlett, Paul A. & Charles K. Marlowe. (1987). An Analysis of the Enzyme-Inhibitor Binding Interactions for Phosphonic Acid Transition State Analogs of Thermolys in. Phosphorous and Sulfur and the Related Elements. 30(3-4). 537–543. 3 indexed citations
17.
Bartlett, Paul A. & Charles K. Marlowe. (1987). Evaluation of Intrinsic Binding Energy from a Hydrogen Bonding Group in an Enzyme Inhibitor. Science. 235(4788). 569–571. 135 indexed citations
18.
Mookhtiar, Kasim A., Charles K. Marlowe, Paul A. Bartlett, & Harold E. Van Wart. (1987). Phosphonamidate inhibitors of human neutrophil collagenase. Biochemistry. 26(7). 1962–1965. 42 indexed citations
19.
Bartlett, Paul A. & Charles K. Marlowe. (1983). Phosphonamidates as transition-state analog inhibitors of thermolysin. Biochemistry. 22(20). 4618–4624. 224 indexed citations
20.
Overman, Larry E., Charles K. Marlowe, & Lane A. Clizbe. (1979). The preparation of N-trichloroacetamido-1,2-dienes. Tetrahedron Letters. 20(7). 599–600. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026